REVANCE THERAPEUTICS, INC., ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF [•], 20__ DEBT SECURITIESIndenture • March 4th, 2015 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [•], 20__, among Revance Therapeutics, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
REVANCE THERAPEUTICS, INC. AND ________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENTPreferred Stock Warrant Agreement • March 4th, 2015 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York
PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of _____ between REVANCE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and _______, a [corporation] [national banking association] organized and existing under the laws of ________ and having a corporate trust office in ________, as warrant agent (the “Warrant Agent”).
REVANCE THERAPEUTICS, INC. AND ________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENTCommon Stock Warrant Agreement • March 4th, 2015 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York
COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of _____ between REVANCE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and _______, a [corporation] [national banking association] organized and existing under the laws of _______ and having a corporate trust office in ________, as warrant agent (the “Warrant Agent”).
FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [__], 20___Warrant Agreement • March 4th, 2015 • Revance Therapeutics, Inc. • Pharmaceutical preparations • New York
DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of _______________ between REVANCE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and ________, a [corporation] [national banking association] organized and existing under the laws of _______ and having a corporate trust office in __________, as warrant agent (the “Warrant Agent”).
